(Q40713714)

23 September 2017

title

Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure (English)

1 reference

ORCID Public Data File 2021

23 September 2017

0 references

1 reference

author name string

Aggarwal A

1

1 reference

23 September 2017

Esler MD

2

1 reference

23 September 2017

Socratous F

3

1 reference

23 September 2017

Kaye DM

4

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Journal of the American College of Cardiology

23 September 2017

published in

1 reference

23 September 2017

volume

37

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

1246-1251

1 reference

Neurohormonal interactions and adaptations in congestive heart failure

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Adverse consequences of high sympathetic nervous activity in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Evidence of a Selective Increase in Cardiac Sympathetic Activity in Patients with Sustained Ventricular Arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Elevation of plasma neuropeptide Y levels in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Prejunctional alpha 2-adrenoceptors and norepinephrine release in the forearm of normal humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Functional significance of presynaptic alpha-adrenergic receptors in failing and nonfailing human left ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Cardiac and systemic sympathetic activity in response to clonidine in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

The central hypotensive effect of clonidine; Studies in tetraplegie subjcets

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Determination of norepinephrine apparent release rate and clearance in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Evidence for functional alpha 2-adrenoceptors on vascular sympathetic nerve endings in the human forearm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Platelet alpha2 adrenoreceptors in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

Sympathoinhibitory Response to Clonidine Is Blunted in Patients With Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure. Moxonidine Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901121-4

7 January 2021

10.1016/S0735-1097(01)01121-4

Identifiers

DOI

1 reference

23 September 2017

1 reference